Clinical trials
Terminated Urinary Bladder Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 3 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 2 |
| Bristol-Myers Squibb | 2 |
| Hopital Foch | 2 |
| University Hospital, Bordeaux | 2 |
| Black Diamond Therapeutics, Inc. | 1 |
| Centre Oscar Lambret | 1 |
| Day One Biopharmaceuticals, Inc. | 1 |
| European Association of Urology Research Foundation | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| G1 Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 21 |
| Carcinoma, Transitional Cell | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Melanoma | 4 |
| Stomach Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.